(LULU) Lululemon Athletica - Overview
Exchange: NASDAQ •
Country: Canada •
Currency: USD •
Type: Common Stock •
ISIN: US5500211090
Stock:
Total Rating 43
Risk 93
Buy Signal -0.56
| Risk 5d forecast | |
|---|---|
| Volatility | 56.7% |
| Relative Tail Risk | -14.5% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.23 |
| Alpha | -65.84 |
| Character TTM | |
|---|---|
| Beta | 0.994 |
| Beta Downside | 0.638 |
| Drawdowns 3y | |
|---|---|
| Max DD | 68.73% |
| CAGR/Max DD | -0.24 |
EPS (Earnings per Share)
Revenue
Description: LULU Lululemon Athletica
lululemon athletica inc., together with its subsidiaries, designs, distributes, and retails technical athletic apparel, footwear, and accessories for women and men under the lululemon brand in the United States, Canada, Mexico, China Mainland, Hong Kong, Taiwan, Macau, and internationally. The company offers pants, shorts, tops, and jackets for athletic activities, such as yoga, running, training, and other activities. It also provides fitness-inspired accessories. The company sells its products through company-operated stores; seasonal stores, pop-ups, university campus retailers, and yoga and fitness studios; outlets; Like New, a re-commerce program; and its e-commerce website. lululemon athletica inc. was founded in 1998 and is based in Vancouver, Canada.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 1.74b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.14 > 0.02 and ΔFCF/TA -8.33 > 1.0 |
| NWC/Revenue: 18.80% < 20% (prev 17.70%; Δ 1.10% < -1%) |
| CFO/TA 0.23 > 3% & CFO 1.86b > Net Income 1.74b |
| Net Debt (726.9m) to EBITDA (2.95b): 0.25 < 3 |
| Current Ratio: 2.13 > 1.5 & < 3 |
| Outstanding Shares: last quarter (118.6m) vs 12m ago -3.46% < -2% |
| Gross Margin: 58.41% > 18% (prev 0.59%; Δ 5782 % > 0.5%) |
| Asset Turnover: 147.3% > 50% (prev 143.7%; Δ 3.53% > 0%) |
| Interest Coverage Ratio: -90.48 > 6 (EBITDA TTM 2.95b / Interest Expense TTM -27.1m) |
Altman Z'' 6.81
| A: 0.26 (Total Current Assets 3.92b - Total Current Liabilities 1.84b) / Total Assets 7.96b |
| B: 0.53 (Retained Earnings 4.20b / Total Assets 7.96b) |
| C: 0.33 (EBIT TTM 2.46b / Avg Total Assets 7.52b) |
| D: 1.12 (Book Value of Equity 3.86b / Total Liabilities 3.45b) |
| Altman-Z'' Score: 6.81 = AAA |
Beneish M -3.31
| DSRI: 0.57 (Receivables 250.3m/400.8m, Revenue 11.07b/10.18b) |
| GMI: 1.01 (GM 58.41% / 58.85%) |
| AQI: 1.02 (AQ_t 0.06 / AQ_t-1 0.06) |
| SGI: 1.09 (Revenue 11.07b / 10.18b) |
| TATA: -0.02 (NI 1.74b - CFO 1.86b) / TA 7.96b) |
| Beneish M-Score: -3.31 (Cap -4..+1) = AA |
What is the price of LULU shares?
As of February 25, 2026, the stock is trading at USD 179.49 with a total of 1,307,779 shares traded.
Over the past week, the price has changed by +1.00%, over one month by -6.90%, over three months by +5.79% and over the past year by -51.25%.
Over the past week, the price has changed by +1.00%, over one month by -6.90%, over three months by +5.79% and over the past year by -51.25%.
Is LULU a buy, sell or hold?
Lululemon Athletica has received a consensus analysts rating of 3.83.
Therefore, it is recommended to buy LULU.
- StrongBuy: 16
- Buy: 3
- Hold: 14
- Sell: 1
- StrongSell: 2
What are the forecasts/targets for the LULU price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 209.1 | 16.5% |
| Analysts Target Price | 209.1 | 16.5% |
LULU Fundamental Data Overview February 24, 2026
P/E Trailing = 13.025
P/E Forward = 13.1406
P/S = 2.0059
P/B = 4.8803
P/EG = 0.9017
Revenue TTM = 11.07b USD
EBIT TTM = 2.46b USD
EBITDA TTM = 2.95b USD
Long Term Debt = 1.76b USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 317.5m USD (from shortTermDebt, last quarter)
Debt = 1.76b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 726.9m USD (from netDebt column, last quarter)
Enterprise Value = 22.94b USD (22.21b + Debt 1.76b - CCE 1.04b)
Interest Coverage Ratio = -90.48 (Ebit TTM 2.46b / Interest Expense TTM -27.1m)
EV/FCF = 20.33x (Enterprise Value 22.94b / FCF TTM 1.13b)
FCF Yield = 4.92% (FCF TTM 1.13b / Enterprise Value 22.94b)
FCF Margin = 10.19% (FCF TTM 1.13b / Revenue TTM 11.07b)
Net Margin = 15.72% (Net Income TTM 1.74b / Revenue TTM 11.07b)
Gross Margin = 58.41% ((Revenue TTM 11.07b - Cost of Revenue TTM 4.61b) / Revenue TTM)
Gross Margin QoQ = 55.57% (prev 58.50%)
Tobins Q-Ratio = 2.88 (Enterprise Value 22.94b / Total Assets 7.96b)
Interest Expense / Debt = 0.46% (Interest Expense 8.03m / Debt 1.76b)
Taxrate = 30.54% (134.9m / 441.7m)
NOPAT = 1.71b (EBIT 2.46b * (1 - 30.54%))
Current Ratio = 2.13 (Total Current Assets 3.92b / Total Current Liabilities 1.84b)
Debt / Equity = 0.39 (Debt 1.76b / totalStockholderEquity, last quarter 4.50b)
Debt / EBITDA = 0.25 (Net Debt 726.9m / EBITDA 2.95b)
Debt / FCF = 0.64 (Net Debt 726.9m / FCF TTM 1.13b)
Total Stockholder Equity = 4.38b (last 4 quarters mean from totalStockholderEquity)
RoA = 23.15% (Net Income 1.74b / Total Assets 7.96b)
RoE = 39.78% (Net Income TTM 1.74b / Total Stockholder Equity 4.38b)
RoCE = 40.01% (EBIT 2.46b / Capital Employed (Equity 4.38b + L.T.Debt 1.76b))
RoIC = 38.99% (NOPAT 1.71b / Invested Capital 4.38b)
WACC = 8.90% (E(22.21b)/V(23.97b) * Re(9.58%) + D(1.76b)/V(23.97b) * Rd(0.46%) * (1-Tc(0.31)))
Discount Rate = 9.58% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.30%
[DCF] Terminal Value 77.97% ; FCFF base≈1.31b ; Y1≈1.58b ; Y5≈2.52b
[DCF] Fair Price = 316.3 (EV 36.21b - Net Debt 726.9m = Equity 35.48b / Shares 112.2m; r=8.90% [WACC]; 5y FCF grow 21.34% → 2.90% )
EPS Correlation: 39.81 | EPS CAGR: -6.78% | SUE: -3.74 | # QB: 0
Revenue Correlation: 60.76 | Revenue CAGR: 5.10% | SUE: 3.85 | # QB: 1
EPS next Quarter (2026-04-30): EPS=2.11 | Chg7d=+0.005 | Chg30d=-0.002 | Revisions Net=+1 | Analysts=15
EPS next Year (2027-01-31): EPS=12.66 | Chg7d=+0.013 | Chg30d=+0.001 | Revisions Net=+5 | Growth EPS=-2.9% | Growth Revenue=+4.3%
[Analyst] Revisions Ratio: +0.33 (2 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 1.9% (Discount Rate 9.6% - Earnings Yield 7.7%)
[Growth] Growth Spread = +2.8% (Analyst 4.7% - Implied 1.9%)
P/E Forward = 13.1406
P/S = 2.0059
P/B = 4.8803
P/EG = 0.9017
Revenue TTM = 11.07b USD
EBIT TTM = 2.46b USD
EBITDA TTM = 2.95b USD
Long Term Debt = 1.76b USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 317.5m USD (from shortTermDebt, last quarter)
Debt = 1.76b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 726.9m USD (from netDebt column, last quarter)
Enterprise Value = 22.94b USD (22.21b + Debt 1.76b - CCE 1.04b)
Interest Coverage Ratio = -90.48 (Ebit TTM 2.46b / Interest Expense TTM -27.1m)
EV/FCF = 20.33x (Enterprise Value 22.94b / FCF TTM 1.13b)
FCF Yield = 4.92% (FCF TTM 1.13b / Enterprise Value 22.94b)
FCF Margin = 10.19% (FCF TTM 1.13b / Revenue TTM 11.07b)
Net Margin = 15.72% (Net Income TTM 1.74b / Revenue TTM 11.07b)
Gross Margin = 58.41% ((Revenue TTM 11.07b - Cost of Revenue TTM 4.61b) / Revenue TTM)
Gross Margin QoQ = 55.57% (prev 58.50%)
Tobins Q-Ratio = 2.88 (Enterprise Value 22.94b / Total Assets 7.96b)
Interest Expense / Debt = 0.46% (Interest Expense 8.03m / Debt 1.76b)
Taxrate = 30.54% (134.9m / 441.7m)
NOPAT = 1.71b (EBIT 2.46b * (1 - 30.54%))
Current Ratio = 2.13 (Total Current Assets 3.92b / Total Current Liabilities 1.84b)
Debt / Equity = 0.39 (Debt 1.76b / totalStockholderEquity, last quarter 4.50b)
Debt / EBITDA = 0.25 (Net Debt 726.9m / EBITDA 2.95b)
Debt / FCF = 0.64 (Net Debt 726.9m / FCF TTM 1.13b)
Total Stockholder Equity = 4.38b (last 4 quarters mean from totalStockholderEquity)
RoA = 23.15% (Net Income 1.74b / Total Assets 7.96b)
RoE = 39.78% (Net Income TTM 1.74b / Total Stockholder Equity 4.38b)
RoCE = 40.01% (EBIT 2.46b / Capital Employed (Equity 4.38b + L.T.Debt 1.76b))
RoIC = 38.99% (NOPAT 1.71b / Invested Capital 4.38b)
WACC = 8.90% (E(22.21b)/V(23.97b) * Re(9.58%) + D(1.76b)/V(23.97b) * Rd(0.46%) * (1-Tc(0.31)))
Discount Rate = 9.58% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.30%
[DCF] Terminal Value 77.97% ; FCFF base≈1.31b ; Y1≈1.58b ; Y5≈2.52b
[DCF] Fair Price = 316.3 (EV 36.21b - Net Debt 726.9m = Equity 35.48b / Shares 112.2m; r=8.90% [WACC]; 5y FCF grow 21.34% → 2.90% )
EPS Correlation: 39.81 | EPS CAGR: -6.78% | SUE: -3.74 | # QB: 0
Revenue Correlation: 60.76 | Revenue CAGR: 5.10% | SUE: 3.85 | # QB: 1
EPS next Quarter (2026-04-30): EPS=2.11 | Chg7d=+0.005 | Chg30d=-0.002 | Revisions Net=+1 | Analysts=15
EPS next Year (2027-01-31): EPS=12.66 | Chg7d=+0.013 | Chg30d=+0.001 | Revisions Net=+5 | Growth EPS=-2.9% | Growth Revenue=+4.3%
[Analyst] Revisions Ratio: +0.33 (2 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 1.9% (Discount Rate 9.6% - Earnings Yield 7.7%)
[Growth] Growth Spread = +2.8% (Analyst 4.7% - Implied 1.9%)